IBIO, INC. Nontrade Receivables, Current
IBIO, INC. (IBIO) had Nontrade Receivables, Current of $1.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:NontradeReceivablesCurrent · last filed 2021-05-17
- 2021-03-31: Nontrade Receivables, Current $1.00K.
- 2020-12-31: Nontrade Receivables, Current $52.00K.
- 2020-06-30: Nontrade Receivables, Current $0.00.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2021-03-31 | $1.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $52.00K 10-Q · filed 2021-02-16 |
| 2020-06-30 | $0.00 10-Q · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |